Redline Capital Partners

Redline Capital is a global venture capital firm that specializes in growth-stage investments within the technology and life sciences sectors. The firm targets innovative companies with proven business models, providing capital and strategic support to accelerate international expansion. Within healthcare, Redline has a significant track record of investing in biotechnology and medical technology companies, particularly those focused on oncology, neurodegeneration, and immunology. Notable portfolio companies include ADC Therapeutics, iTeos Therapeutics, and Asceneuron. The firm typically invests in companies that have already reached clinical stages or have demonstrated significant technological de-risking. Redline operates primarily out of Luxembourg and London, focusing on opportunities in Europe, North America, and Israel.